Navigating the Nexus of Addiction, HCV Infection, and HIV Infection

What can you do in your clinic to ensure all people who use drugs are screened for HCV and are offered treatment if they have HCV infection?

Andrew Seaman, MD Released: February 24, 2020

In this CME/CE/CPE-certified interactive video module, CCO’s expert faculty provide insights on the critical role ID specialists and hepatologists can play in addressing the ongoing opioid use disorder (OUD) epidemic and discuss useful strategies for incorporating OUD screening, patient evaluation, and treatment into HIV/HCV care settings.

Sandra Springer, MD
Program Director Christian B. Ramers, MD, MPH Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Registered Nurses: 1.75 Nursing contact hours Pharmacists: 1.75 contact hours (0.175 CEUs) Released: February 6, 2020 Expiration: February 5, 2021

Introduction and Overview of the Intersection Betweeen Opioid Use Disorder and Infectious Diseases (19 mins)

Benefits of and Need for Combined Addiction and Infectious Disease Care (20 mins)

Getting Started With Addiction Care: Screening and Evaluation (16 mins)

Overview of Medication Treatment for OUD (10 mins)

Additional Considerations for HIV/HCV and OUD Comanagement and Call to Action (11 mins)

Download this slideset to learn more about the integral role infectious disease specialists and hepatologists can play in combatting the opioid use disorder (OUD) epidemic, including essential strategies for integrating OUD screening, evaluation, and treatment into HIV and HCV care settings.

Sandra Springer, MD
Program Director Christian B. Ramers, MD, MPH Released: February 6, 2020